| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Center for Stroke Research, Department of Neurology and Rehabilitation, Chicago, Ill. * To whom correspondence should be addressed. E-mail: pgorelic{at}uic.edu.
Related Article:
Uncertainty of Management of Blood Pressure and Lipids in the Elderly. Time for a Primary Prevention Trial
Philip B. Gorelick MD, MPH, FACP*
Key words: prevention
Stroke 2007 38: 441-450.
This article has been cited by other articles:
![]() |
P. B. Gorelick Cerebral Microbleeds: Evidence of Heightened Risk Associated With Aspirin Use Arch Neurol, June 1, 2009; 66(6): 691 - 693. [Full Text] [PDF] |
||||
![]() |
P. B. Gorelick Challenges of Designing Trials for the Primary Prevention of Stroke Stroke, March 1, 2009; 40(3_suppl_1): S82 - S84. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |